Latest Press Releases
More Press Releases
KANZHUN LIMITED Announces Change of Directors’ Executive Positions
BEIJING, Sept. 01, 2026 (GLOBE NEWSWIRE) — KANZHUN LIMITED (“BOSS Zhipin” or the “Company”) (Nasdaq: BZ; HKEX: 2076),
Pyxis Oncology to Participate in Upcoming Investor Conferences
BOSTON, Sept. 01, 2026 (GLOBE NEWSWIRE) — Pyxis Oncology, Inc. (Nasdaq: PYXS), a clinical-stage company developing
Telesat Government Solutions and Cailabs Collaborate on Secure Optical Connectivity for Government Missions
Strategic collaboration agreement explores interoperability between Telesat Lightspeed advanced low Earth orbit network
FocalTherics™ to Present at the H.C. Wainwright 28th Annual Global Investment Conference
Company to Present and Host 1×1 Investor Meetings on Tuesday and Wednesday, September 15th-16th, 2026
USBC Expands Leadership Team with Former JPMorgan Chase and Coinbase Product Executive
Richa Pareek, new Chief Product Officer, to Lead USBC’s Next Phase of Platform Development
Vera Therapeutics to Participate at Upcoming Investor Conferences
BRISBANE, Calif., Sept. 01, 2026 (GLOBE NEWSWIRE) — Vera Therapeutics, Inc. (Nasdaq: VERA), a commercial-stage
COMSTOCK ANNOUNCES $1.65 BILLION STRATEGIC PARTNERSHIP WITH SOCAR AND $450 MILLION DRILLING JOINT VENTURE WITH JERRY JONES
FRISCO, TX, Sept. 01, 2026 (GLOBE NEWSWIRE) — Comstock Resources, Inc. (NYSE and NYSE Texas: CRK) ("Comstock" or the
BridgeBio to Participate in September Investor Conferences
PALO ALTO, Calif., Sept. 01, 2026 (GLOBE NEWSWIRE) — BridgeBio Pharma, Inc. (Nasdaq: BBIO) (“BridgeBio” or the
Alumis Announces Topline Results from Envudeucitinib Phase 2b Trial in Systemic Lupus Erythematosus (SLE)
– LUMUS trial did not meet its primary and secondary endpoints in the overall trial population – – Robust responses in
Bitcoin Bancorp Reports Second Quarter Revenue and Raises Full-Year 2026 Revenue Outlook
Expansion of Bitcoin ATM network continues to accelerate growth, increasing projected annual revenue to $5.4M-$5.5M, a